Hurler-Scheie Syndrome
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotype.
|
1301196 |
1992 |
Hurler-Scheie Syndrome
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
alpha-L-iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotype.
|
1301941 |
1992 |
Hurler-Scheie Syndrome
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Two novel mutations causing mucopolysaccharidosis type I detected by single strand conformational analysis of the alpha-L-iduronidase gene.
|
8401515 |
1993 |
Hurler-Scheie Syndrome
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Mucopolysaccharidosis type I: identification of 13 novel mutations of the alpha-L-iduronidase gene.
|
7550242 |
1995 |
Hurler-Scheie Syndrome
|
0.770 |
GermlineCausalMutation
|
disease |
ORPHANET |
Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications.
|
8680403 |
1995 |
Hurler-Scheie Syndrome
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
We report on novel mutations of the IDUA gene in one patient with the Scheie syndrome and in three patients with the Hurler/Scheie syndrome.
|
7550232 |
1995 |
Hurler-Scheie Syndrome
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
We report on novel mutations of the IDUA gene in one patient with the Scheie syndrome and in three patients with the Hurler/Scheie syndrome.
|
7550232 |
1995 |
Hurler-Scheie Syndrome
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
alpha-L-Iduronidase (IDUA) deficiency (mucopolysaccharidosis type I, MPS I) involves a broad spectrum of clinical severity ranging from a severe Hurler syndrome through an intermediate Hurler Scheie syndrome to a mild Scheie syndrome.
|
10466419 |
1999 |
Hurler-Scheie Syndrome
|
0.770 |
Biomarker
|
disease |
BEFREE |
alpha-L-Iduronidase (IDUA) deficiency (mucopolysaccharidosis type I, MPS I) involves a broad spectrum of clinical severity ranging from a severe Hurler syndrome through an intermediate Hurler Scheie syndrome to a mild Scheie syndrome.
|
10466419 |
1999 |
Hurler-Scheie Syndrome
|
0.770 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Identification and characterization of -3c-g acceptor splice site mutation in human alpha-L-iduronidase associated with mucopolysaccharidosis type IH/S.
|
10735634 |
2000 |
Hurler-Scheie Syndrome
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
Identification and characterization of -3c-g acceptor splice site mutation in human alpha-L-iduronidase associated with mucopolysaccharidosis type IH/S.
|
10735634 |
2000 |
Hurler-Scheie Syndrome
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Identification and characterization of -3c-g acceptor splice site mutation in human alpha-L-iduronidase associated with mucopolysaccharidosis type IH/S.
|
10735634 |
2000 |
Hurler-Scheie Syndrome
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations.
|
11735025 |
2001 |
Hurler-Scheie Syndrome
|
0.770 |
Biomarker
|
disease |
CTD_human |
Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation.
|
11159948 |
2001 |
Hurler-Scheie Syndrome
|
0.770 |
Therapeutic
|
disease |
CTD_human |
Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation.
|
11159948 |
2001 |
Hurler-Scheie Syndrome
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients.
|
12559846 |
2003 |
Hurler-Scheie Syndrome
|
0.770 |
Therapeutic
|
disease |
CTD_human |
alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients.
|
15081804 |
2004 |
Hurler-Scheie Syndrome
|
0.770 |
Biomarker
|
disease |
CTD_human |
Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase gene.
|
15194053 |
2004 |
Hurler-Scheie Syndrome
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
|
15300847 |
2004 |
Hurler-Scheie Syndrome
|
0.770 |
Therapeutic
|
disease |
CTD_human |
Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase gene.
|
15194053 |
2004 |
Hurler-Scheie Syndrome
|
0.770 |
Biomarker
|
disease |
CTD_human |
alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients.
|
15081804 |
2004 |
Hurler-Scheie Syndrome
|
0.770 |
Biomarker
|
disease |
CTD_human |
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.
|
19309154 |
2009 |
Hurler-Scheie Syndrome
|
0.770 |
Therapeutic
|
disease |
CTD_human |
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.
|
19309154 |
2009 |
Hurler-Scheie Syndrome
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation.
|
19751987 |
2010 |
Hurler-Scheie Syndrome
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
IDUA mutational profiling of a cohort of 102 European patients with mucopolysaccharidosis type I: identification and characterization of 35 novel α-L-iduronidase (IDUA) alleles.
|
21394825 |
2011 |